AIPTO TechBio GmbH

The company aims to develop biotechnology and therapy for brain cancer based on patient avatars and artificial intelligence. The company may establish branches and subsidiaries in Switzerland and abroad and participate in other companies in Switzerland and abroad, as well as conduct all business that is directly or indirectly related to its purpose. The company may acquire, encumber, sell and manage real estate in Switzerland and abroad. It may also provide financing for its own account or for the account of third parties, as well as grant guarantees and warranties for subsidiaries and third parties.